Today's 3 Best Stocks

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

With economic data taking a back seat for at least one day, a slew of better-than-expected earnings and strength from the financial sector -- which is often seen as the backbone of any rally -- led the broad-based S&P 500 (SNPINDEX: ^GSPC  ) to yet another record close.

Fears constrained the market yesterday that the Federal Reserve would soon pare back its bond-buying stimulus, which could have a negative effect on interest rates. However, the Fed has also stood firm in its stance of maintaining record-low target rates through 2015, which should help alleviate fears that a slowdown would soon follow the Fed's actions.

All told, the S&P 500 ended high by 16.57 points (1.01%) to close at 1,650.34. As you've probably come to expect, big gains in the indexes often lead to even bigger gains for some of its components. Here's a look at the three top performers today.

For-profit education company Apollo Group (NASDAQ: APOL  ) , known best for its University of Phoenix campuses, rallied 9.1% after its University of Phoenix received a letter recommending the reaffirmation of its accreditation for another 10 years from the HLC Institutional Actions Council. Becoming accredited is the first step to getting funds from the government, so this is a big step at a time when government scrutiny over the actions of for-profit colleges is under close examination. Despite this news, I'd still keep my distance, with enrollments weak and the cost of a secondary education at many of these schools tough to justify.

Edwards Lifesciences (NYSE: EW  ) , which makes surgical heart valve therapy products, rose 6.3% after announcing a $750 million share repurchase program and noting that its CFO, Thomas Abate, planned to retire by the end of the year. Edwards has had a rough year with the implementation of the medical device excise tax constraining its results and its Sapien heart valves growing by a slower-than-expected 25%-30% instead of the originally projected 30%-45%. This buyback program should help put a floor in shares over the interim, but Edwards certainly can't afford any more earnings disappointments if it hopes to retain its already pricey forward P/E of 20.

Finally, online trip advisory service TripAdvisor (NASDAQ: TRIP  ) took flight and advanced 5.9% after issuing a survey indicating that U.S. travel is expected to surge this summer. The poll determined that 86% of the some 1,200 people surveyed expect to take a leisure trip sometime in 2012, versus only 79% when this same poll was conducted last year. This would certainly be good news for travel review sites like TripAdvisor, but it could even be better news for third-party travel agents such as (NASDAQ: PCLN  ) . Priceline has had incredible success overseas and may need only a slight boost in domestic spending to continue to take market share from its rivals and head toward the psychological $1,000-per-share mark.

How dangerous is the medical device excise tax to the device sector?
Obamacare will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 30, 2013, at 1:30 AM, babypancakes wrote:

    Here is what will happen with APOL. Right now it is trading around $20. A month or two ago it was bottomed at around $16. This is a stock that is sure to go up, a lot. The HLC will eventually put University of Phoenix on probation. APOL gets 90% of its revenue from Phoenix. I am guessing that the stock may take another plunge. However, the University is "too big to fail" (please pardon the cliche). Eventually the HLC will give full accreditation to Phoenix, and when this happens, I predict a very large increase in the price per share. $20 per is still a good price, anything lower is gravy.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2430745, ~/Articles/ArticleHandler.aspx, 9/26/2016 5:15:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,094.83 -166.62 -0.91%
S&P 500 2,146.10 -18.59 -0.86%
NASD 5,257.49 -48.26 -0.91%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 4:35 PM
^GSPC $2146.10 Down -18.59 -0.86%
S&P 500 INDEX CAPS Rating: No stars
APOL $7.71 Up +0.13 +1.72%
Apollo Group CAPS Rating: *
EW $118.94 Down -0.83 -0.69%
Edwards Lifescienc… CAPS Rating: ****
TRIP $61.89 Up +0.02 +0.03%
TripAdvisor CAPS Rating: *****
PCLN $1447.15 Down -9.61 -0.66%
Priceline Group CAPS Rating: ****